Sorted By:


PhRMA Statement on Sustainability & Manufacturing Process

PhRMA  |  Press Release

In the process of manufacturing new medicines, a facility must comply with state guidelines on waste management as well as local water board and municipality regulations that control pre-treatment and testing practices of wastewater streams.

The Value Collaborative: Advancing private market solutions to achieve better health, lower costs

PhRMA  |  Blog Post

That is why we have proposed commonsense policy solutions to address the legal and regulatory barriers that currently exist and why we, as an industry, are investing in the development and use of tools for better measurement of outcomes and the creation of value frameworks that keep the needs of the patient in mind.

Medicare Monday: Helping beneficiaries access vaccines

PhRMA  |  Blog Post

These include vaccines for Alzheimer’s disease, which in 2016 cost Medicare an average of $23,497 in annual per-person payments for beneficiaries with Alzheimer’s or other dementias.

The 20-year journey yielding a new weapon against cancer

PhRMA  |  Video

Nearly 30 years ago, the scientific community identified BCL-2 proteins and their role in blocking the ability of cells in the body to undergo a process called programmed cell death or apoptosis, through which the body gets rid of damaged cells.

Stephen J. Ubl

PhRMA  |  Biography

Ubl has worked extensively with patient advocacy organizations in health policy, including longstanding service on the board of the National Health Council, a leading umbrella organization for voluntary health care organizations and has been personally involved with JDRF (formerly known as the Juvenile Diabetes Research Foundation).

Senior Director - Public Affairs

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.


PhRMA  |  From PhRMA

However, hospitals acquiring more independent physician practices, which enable the formerly independent practices to access the hospitals’ 340B discounts, can drive up costs for patients and payers, in addition to reducing patient access to community treatment options.

Medicines in Development for HIV 2017 Report

PhRMA  |  Report

Since the human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency syndrome (AIDS), was first identified in the United States more than 30 years ago, expanded treatment options have brought down death rates, increased patient adherence, improved the quality of life for patients and paved the way for future research focused on preventing the disease.

Forced pharmaceutical localization fails to deliver

PhRMA  |  Blog Post

Indeed, countries such as Singapore, Denmark and Ireland, while small in market size, are found to have the most attractive policy and supportive environment with a strong long-term focus on positive incentives.

Empowering consumers and improving access to important clinical information

PhRMA  |  Blog Post

Another policy solution is to improve access to information about medication restrictions and the clinical information used to establish them.

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

PhRMA  |  Blog Post

Hugin, Executive Chairman, Celgene Ripley Ballou, Vice President of GSK Vaccines and Head of Slaoui Center for Vaccines Research, joined the “Future Vaccine” panel looking at the impact of genomics on how we develop vaccines.

Clarity around anti-kickback statute needed to promote innovative payment arrangements

PhRMA  |  Blog Post

Learn more at

Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman

PhRMA  |  Press Release

Duato joined Johnson & Johnson in 1989 in Janssen-Cilag Spain and later became managing director of Janssen-Cilag Italy.

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

PhRMA  |  Blog Post

Following implementation of the new system, the Medicare Payment Advisory Commission reported in January 2007 that “As intended by the policy, payment rates for drugs were reduced to levels closer to provider purchase prices.”

Kenneth Thorpe, Ph.D.

PhRMA  |  Biography

He has appeared on Nightline with Ted Koppel, NBC News with Tom Brokaw, ABC World News Tonight with Peter Jennings, CNN, CNBC and Newshour with Jim Lehrer.

New JAMA Study Highlights Continued Success of Medicare Part D

PhRMA  |  Press Release

While the research is not specific to any one policy or event, proposals such as government-mandated Part D rebates would be expected to have revenue impact of this magnitude.

A new era in cancer

PhRMA  |  Blog Post

Elizabeth Jaffee of Johns Hopkins, Sean Parker of the Parker Institute for Cancer Immunotherapy and Mark Alles, chief executive officer at Celgene.

Ask About Adherence: Q&A on appointment-based medication synchronization

PhRMA  |  Blog Post

These results suggest that payer partnerships with pharmacies offering ABMS are economical and provide a positive return on investment.

Treatment Costs of Parkinson's Disease

PhRMA  |  Graphic


Chart Pack: Biopharmaceuticals in Perspective

PhRMA  |  Report

Data and information in this publication were drawn from a wide range of sources, including government agency reports, peer-reviewed journals, and the Pharmaceutical Research and Manufacturers of America’s (PhRMA’s) own research and analysis.

A new kind of Chart Pack

PhRMA  |  Blog Post

Data and information in this report comes from a wide range of sources, including government agency reports, peer?

Vice President Biden Will Head Pursuit Of Cancer Cure

From Hope To Cures  |  From Our Network

“There’s no question they are in the process of compiling information, talking to the broader cancer research community, so they can get a broad spectrum of ideas,” said Jon Retzlaff, AACR’s policy director.

New video: Patient and researcher fight JRA together

PhRMA  |  Blog Post

Parker can live long and active lives.

Who gets a seat at ICER’s table? Hint: It’s not patients

PhRMA  |  Blog Post

Read more about PhRMA’s policy solutions to promote value-driven health care here.

Preventive Care And High Deductibles Work At Cross Purposes, Covered Cal Chief Says

Access Better Coverage  |  From Our Network

Elliott Fisher, director of the Dartmouth Institute for Health Policy and Clinical Practice.

You have reviewed the first 225 results out of 1101. Each page contains 25 results. You're on page 9.

prev 7 8 9 10 11 12 next